[HTML][HTML] Antibodies to combat viral infections: development strategies and progress

G Pantaleo, B Correia, C Fenwick, VS Joo… - Nature Reviews Drug …, 2022 - nature.com
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for
viral infections owing to characteristics such as their high specificity and their ability to …

[HTML][HTML] Antibodies to combat viral infections: development strategies and progress

G Pantaleo, B Correia, C Fenwick, VS Joo… - Nature Reviews. Drug …, 2022 - ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for
viral infections owing to characteristics such as their high specificity and their ability to …

Antibodies to combat viral infections: development strategies and progress

G Pantaleo, B Correia, C Fenwick… - Nature reviews …, 2022 - pubmed.ncbi.nlm.nih.gov
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for
viral infections owing to characteristics such as their high specificity and their ability to …

[PDF][PDF] Antibodies to combat viral infections: development strategies and progress

G Pantaleo, B Correia, C Fenwick, VS Joo… - Nature reviews| Drug … - researchgate.net
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophy lactics for
viral infections owing to characteristics such as their high specificity and their ability to …

[PDF][PDF] Antibodies to combat viral infections: development strategies and progress

G Pantaleo, B Correia, C Fenwick, VS Joo… - Nature reviews| Drug … - serval.unil.ch
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophy lactics for
viral infections owing to characteristics such as their high specificity and their ability to …

[PDF][PDF] Antibodies to combat viral infections: development strategies and progress

G Pantaleo, B Correia, C Fenwick, VS Joo… - Nature reviews| Drug … - core.ac.uk
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophy lactics for
viral infections owing to characteristics such as their high specificity and their ability to …

Antibodies to combat viral infections: development strategies and progress

G Pantaleo, B Correia, C Fenwick… - Nature Reviews Drug …, 2022 - infoscience.epfl.ch
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for
viral infections. This Review describes advances in antibody discovery and engineering that …

Antibodies to combat viral infections: development strategies and progress.

G Pantaleo, B Correia, C Fenwick, VS Joo… - Nature reviews. Drug …, 2022 - europepmc.org
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophylactics for
viral infections owing to characteristics such as their high specificity and their ability to …

[PDF][PDF] Antibodies to combat viral infections: development strategies and progress

G Pantaleo, B Correia, C Fenwick, VS Joo… - Nature reviews| Drug … - serval.unil.ch
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophy lactics for
viral infections owing to characteristics such as their high specificity and their ability to …

[PDF][PDF] Antibodies to combat viral infections: development strategies and progress

G Pantaleo, B Correia, C Fenwick, VS Joo, L Perez - infoscience.epfl.ch
Monoclonal antibodies (mAbs) are appealing as potential therapeutics and prophy lactics for
viral infections owing to characteristics such as their high specificity and their ability to …